EICHOR
● Active Not Recruiting
A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus · Sponsor: Bristol-Myers Squibb
About this study
The purpose of this study is to evaluate the effectiveness, safety and tolerability of Afimetoran in participants with active Systemic Lupus Erythematosus (SLE). The extension period will provide additional long-term safety and efficacy data and enable those participants initially randomized to placebo to receive treatment with Afimetoran.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (147)
| Local Institution - 0100 | Birmingham, Alabama, United States | — |
| Local Institution - 0123 | Huntington Beach, California, United States | — |
| Local Institution - 0170 | La Jolla, California, United States | — |
| Local Institution - 0159 | La Palma, California, United States | — |
| Local Institution - 0172 | San Diego, California, United States | — |
| Local Institution - 0164 | Woodland Hills, California, United States | — |
| Local Institution - 0121 | Clearwater, Florida, United States | — |
| Local Institution - 0167 | Kissimmee, Florida, United States | — |
| Local Institution - 0122 | Orlando, Florida, United States | — |
| Local Institution - 0173 | Ormond Beach, Florida, United States | — |
| Local Institution - 0154 | Plantation, Florida, United States | — |
| Local Institution - 0137 | South Miami, Florida, United States | — |
+ 135 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04895696